» Articles » PMID: 24740742

Osteosarcopenic Obesity: the Role of Bone, Muscle, and Fat on Health

Overview
Date 2014 Apr 18
PMID 24740742
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Osteopenia/osteoporosis, sarcopenia, and obesity are commonly observed in the process of aging, and recent evidence suggests a potential interconnection of these syndromes with common pathophysiology. The term osteosarcopenic obesity has been coined to describe the concurrent appearance of obesity in individuals with low bone and muscle mass. Although our understanding of osteosarcopenic obesity's etiology, prevalence, and consequences is extremely limited, it is reasonable to infer its negative impact in a population that is aging in an obesogenic environment. It is likely that these individuals will present with poorer clinical outcomes caused by the cascade of metabolic abnormalities associated with these changes in body composition. Clinical outcomes include but are not limited to increased risk of fractures, impaired functional status (including activities of daily living), physical disability, insulin resistance, increased risk of infections, increased length of hospital stay, and reduced survival. These health outcomes are likely to be worse when compared to individuals with obesity, sarcopenia, or osteopenia/osteoporosis alone. Interventions that utilize resistance training exercise in conjunction with increased protein intake appear to be promising in their ability to counteract osteosarcopenic obesity.

Citing Articles

The link between Mitochondria and Sarcopenia.

Kamarulzaman N, Makpol S J Physiol Biochem. 2025; .

PMID: 39969761 DOI: 10.1007/s13105-024-01062-7.


Undernutrition risk and obesity increase the risk of osteosarcopenia in Mexican adults aged 50 and over: a prospective cohort study.

Omana-Guzman I, Kammar-Garcia A, Gutierrez-Robledo L, Rosas-Carrasco O Front Nutr. 2025; 11:1499453.

PMID: 39902393 PMC: 11788158. DOI: 10.3389/fnut.2024.1499453.


Role of sirtuins in obesity and osteoporosis: molecular mechanisms and therapeutic targets.

Du Y, Huo Y, Yang Y, Lin P, Liu W, Wang Z Cell Commun Signal. 2025; 23(1):20.

PMID: 39799353 PMC: 11724515. DOI: 10.1186/s12964-024-02025-7.


Prevalence, risk factors, and adverse outcomes of diastasis of rectus abdominis in men: a cross-sectional study.

Zhu C, Shen Y, Wang L, Gu Y, Yu X, Wu L Hernia. 2024; 29(1):31.

PMID: 39601914 DOI: 10.1007/s10029-024-03225-3.


MRI-Based Phenotyping for Osteosarcopenic Adiposity in Subjects from a Population-Based Cohort.

Maurer E, Rospleszcz S, Rathmann W, Thorand B, Peters A, Schlett C Geriatrics (Basel). 2024; 9(6).

PMID: 39584951 PMC: 11587111. DOI: 10.3390/geriatrics9060150.


References
1.
Pi-Sunyer F . Obesity: criteria and classification. Proc Nutr Soc. 2000; 59(4):505-9. DOI: 10.1017/s0029665100000732. View

2.
Li Z, Heber D . Sarcopenic obesity in the elderly and strategies for weight management. Nutr Rev. 2012; 70(1):57-64. DOI: 10.1111/j.1753-4887.2011.00453.x. View

3.
Yang S, Alnaqeeb M, Simpson H, Goldspink G . Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil. 1996; 17(4):487-95. DOI: 10.1007/BF00123364. View

4.
Toigo M, Boutellier U . New fundamental resistance exercise determinants of molecular and cellular muscle adaptations. Eur J Appl Physiol. 2006; 97(6):643-63. DOI: 10.1007/s00421-006-0238-1. View

5.
Prado C, Wells J, Smith S, Stephan B, Siervo M . Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012; 31(5):583-601. DOI: 10.1016/j.clnu.2012.06.010. View